This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The S&P/TSX Cannabis Index lost a fraction to 204.57, while the CSE Composite Index added 3.23 to 788.19. It was a day of big winners, big losers and big financings. One of today's noteworthy gainers was Cannabix Technologies Inc. (BLO), which shot up 55 cents to $1.49 on 5.78 million shares, after receiving a U.S. patent for intellectual property related to its cannabis breathalyzer. It has been pursuing this patent for seven years.

The long wait partly reflects a long wade through a sea of red tape, dating back to when Cannabix obtained a licence for the original version of the patent application in 2014. (The licensor was a company founded by RCMP-officer-turned-entrepreneur Kal Malhi, who along with Vancouver radiologist Dr. Raj Attariwala is credited as the inventor behind the patent. Mr. Malhi and Dr. Attariwali are the co-founders of Cannabix and serve as its president and chief scientific officer, respectively.) The changing names on the application added extra complications to what is already a notoriously slow process. Yet now, at long last, the patent has been granted. Dr. Attariwali cheered that the patent "gives Cannabix a broad foundation to build upon, in view of the formidable insights and technical advancements ... that we have developed since this patent was initially filed in 2014."

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS